Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Centriole Finding Expands Knowledge of Cancer Cell Biology
Disease Discoveries

Centriole Finding Expands Knowledge of Cancer Cell Biology

By Nora DunneJun 29, 2015
Share
Facebook Twitter Email
Brian-Mitchell-PhD
Brian Mitchell, PhD, assistant professor in Cell and Molecular Biology, was a coauthor of a paper that identified a new compound for studying centrioles.

A new study coauthored by Northwestern Medicine scientists has found that normal cells stop proliferating when they lose important intracellular structures called centrioles, but cancer cells continue to multiply.

The paper, published in Science, settles an old debate about the role these structures play in cancer. Previously, many cell biologists thought that blocking centrioles from forming could stop cancer growth, because many advanced cancers have too many centrioles (a normal human cell has two; together they make up the centrosome).

“The regulation of centriole duplication has been the subject of intense investigation by many groups,” said coauthor Brian Mitchell, PhD, assistant professor in Cell and Molecular Biology. “It was a very surprising finding that normal but not cancer cells were blocked from dividing. ”

In the study, scientists from the Ludwig Institute for Cancer Research developed a small molecule compound called Centrinone that inhibits Plk4, a protein kinase that regulates centriole assembly.

“Normal cells treated with this inhibitor will eventually lose their centrioles and stop dividing. Interestingly, cancer cells will lose their centrioles but are still capable of dividing, albeit at a decreased rate,” Mitchell said.

The finding has broad applications: In addition to cell division, centrioles are involved in forming cilia, hair-like organelles lining the surfaces of some cells that are also linked to numerous diseases.

Mitchell’s lab conducted the first in vivo analysis of Centrinone, showing that the compound inhibits centriole formation in ciliated epithelial cells.

“This compound is destined to be the standard in the field that will allow a detailed analysis of Plk4 in numerous contexts that were previously untenable due to the importance of this protein for cell survival,” said Mitchell, who is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

The study was supported by National Institutes of Health grants GM074207 and GM089970 and the Hilton Ludwig Cancer Prevention Initiative.

Cancer Cell and Developmental Biology Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Comments are closed.

Latest News

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
pride7
pride6
pride5
pride4
pride3
pride2
pride1
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.